COPENHAGEN, Denmark, Sept. 29, 2026 -- Breye Therapeutics ApS (Breye), a clinical-stage biopharmaceutical company developing oral therapeutics for the early treatment of retinal diseases, today announced the successful close of...
Art Pappas will participate on a panel at the C21 BioVentures Conference in Napa, Ca titled "Structured Acquisitions: Win-Win or Lose-Lose?"
News | 04. 08. 2009
